Key result
Total bilirubin shows J-shaped association with post-MI major cardiovascular events, linked to ~24% lower risk at moderate levels.
Cohort (n=3,809)
Answers are grounded in this paper and cite their sources.
Background: Although experimental studies have demonstrated the protective role of total bilirubin (TBil) in cardiovascular diseases, several previous clinical observations are controversial. More importantly, no data are currently available regarding the relation of TBil to major adverse cardiovascular events (MACE) in patients with previous myocardial infarction (MI). Objectives: This study sought to explore the association between TBil and long-term clinical outcomes in patients with previous MI. Methods: A total of 3,809 patients who are post-MI were consecutively enrolled in this prospective study. Cox regression models using HRs and CIs were applied to investigate associations between the TBil concentration category (group 1: bottom to median tertiles within the reference range; group 2: top tertile; group 3: above reference range) and main outcome (recurrent MACE) as well as secondary outcomes (hard endpoints and all-cause mortality). Results: 0.001). When compared with the reference group (group 1) in multivariable analysis, a J-shaped association was apparent for MACE, with decreased risk in group 2 (HR: 0.76; 95% CI: 0.59-0.96) and elevated risk in group 3 (HR: 1.29; 95% CI: 1.03-1.61). Similar associations were identified regarding hard endpoints and all-cause mortality. Moreover, TBil demonstrated incremental discriminatory strength when added to the predictive model. Conclusions: In this prospective cohort study with long-term follow-up, higher TBil levels within the physiological range reduced the incidence of long-term cardiovascular events in patients who are post-MI.
No takes yet. Share an insight, caveat, or question.
Cao et al. (2023) conducted a cohort in Previous myocardial infarction (n=3,809). Circulating total bilirubin (TBil) concentration vs. Bottom to median tertiles of TBil within the reference range (group 1) was evaluated on Recurrent major adverse cardiovascular events (MACE) (HR 0.76, 95% CI 0.59-0.96). Circulating total bilirubin showed a J-shaped association with recurrent major cardiovascular events post-MI, with lower risk in the top reference tertile and higher risk above reference.
Synapse has enriched 10 related papers. Consider them for comparative context: